In Conversation With Amgen - A Biotechnology Company

How have pharmaceutical and biotechnology organisations adapted to emerging challenges since the onset of COVID-19? What can/is being done to build resilience in the medium-to-long term when it comes to: employee health, mental health & well-being; testing and vaccination, and return to operations? 

In this industry-specific virtual fireside chat, we shine the spotlight on Amgen - one of the world’s leading biotechnology companies.

Their Executive Director of Occupational Health - Nila Cainglit, share their experience and insights on how they are managing the current and future health, safety and well-being of their employees globally.